The mouse that roared,...or another snake oil?
http://www.newswire.ca/cgi-bin/view.cgi?OKEY=64484&BIN=ME
ASAP Gets Drug Approval and Malaria Test Results
ALPINE, UT, Oct. 4 /CNW/ - Clifton Mining Company (OTC: CFTN) is pleased
to announce that American Biotech Labs, a company in which Clifton owns
approximately 30% has just received its first international drug approval and
hospital trials have shown outstanding results using the ASAP Solution(R)
against a wide range of diseases including Malaria.
The Testing
Hospital testing of the ASAP Solution(R), as an antibiotic alternative,
in Ghana, West Africa has met with such significant results that the Food and
Drug Board of Ghana has already approved the ASAP Solution(R) for drug
registration. Testing of the product in hospitals has been going on for over a
year, reports Keith Moeller VP, "We never dreamed that the human testing of
the product could have gone this well. We already have results in from the
first 60 patients, and we are waiting for information on approximately 120
more."
In the testing, which was conducted in hospitals by medical doctors, the
ASAP Solution(R) was used as a treatment for a variety of diseases and
conditions such as malaria, fungal skin infections, vaginal infections,
urinary tract infections, tonsilitis, pharingitis, gonorrhea, conjunctivitis,
upper respiratory tract infections, nasal and sinus problems. Said Moeller,
"In the first 60 human cases which we have record of, the doctors reported no
failures at all. In fact, almost all conditions showed full recovery within
1-7 days, and in the case of one eye infection, the doctor reported immediate
relief.
Malaria Tests
Malaria is reportedly the number two infectious killer in the world,
killing approximately 1.5 million people, mostly children, annually. An
outbreak of several new cases was recently reported in the United States in
Virginia. Of the first 60 patents treated in the hospitals with the ASAP
Solution(R), there were eight reported malaria patients. Some of the cases
were reported as having "severe malaria". The patients ages were 8, 18, 35,
45, 51, 53, 56, and 75. The doctors reported that all eight malaria cases were
fully recovered within just seven days. Said Moeller, "We are very excited
about the test results and the drug approval. We can now sell the product in
West Africa and we expect to be shipping hundreds of thousands of bottles of
the ASAP Solution(R) to Africa before the end of the year. We are just on the
tip of the iceberg. Thousands of doctors and companies have been searching for
a treatment for malaria with limited success. Whereas, the test results of
ASAP Solution(R) are very positive. A new series of human trials has already
begun in Africa specializing in the treatment of malaria alone. We hope to
have those results soon. In conjunction with the results we released a few
weeks ago, showing the products ability to kill the MRSA super bacteria and
the new human test data including the treatment of malaria, we feel like the
mouse that roared!"
Clifton trades on the U.S. OTC: (CFTN).
Note: Any statements released by Clifton Mining Company that are forward
looking are made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. Editors and investors are cautioned
that forward looking statements invoke risk and uncertainties that may affect
the company's business prospects and performance. These include economic,
competitive, governmental, technological and other factors discussed in the
company's business plan and due-diligence information.
-30-
For further information: Keith W. Moeller, V.P. at Clifton Mining
Company, (801) 756-1414 ext. 41, or see our websites at www.cliftonmining.com,
or American Biotech Labs' web site at www.asapsolution.com
*****************************************************
I hesitated to to publish this news release in Sept to the thread, but the thing is now the mouse that roared so I can no longer hold this back from the thread (ggggggggggg),...I wondered what shape the patient would be in after use earlier, but results from Africa seem to indicate the patients survive and thrive.
ASAP Kills Resistant Hospital Staff Infection
ALPINE, UTAH, Sept. 16 /CNW/ - Clifton Mining Company (OTC: CFTN) is
pleased to announce that American Biotech Labs, a company in which Clifton
owns approximately 30% has just finished its first set of tests using the ASAP
Solution(R) against the MRSA (Methicillin-resistant Staphylococcus aureus)
bacteria as well as Candida albicans yeast and the Trichomonas vaginalis
bacteria.
Staphylococcus aureus can cause serious blood poisoning when it enters a
wound. It was once easily treated with penicillin, but it has now mutated to
the point where it is totally resistant to it. The next defense on the
antibiotic ladder has been methicillin, but the strains of the bug that are
resistant to methicillin have become increasingly common, especially in
hospitals. They are known as MRSA (Methicillin-resistant Staphylococcus
aureus) - dubbed the superbug. People who contract the MRSA superbug
infections in hospitals can die in a matter of days.
In the test work, the 10 ppm ASAP Solution(R) was tested against six
million colony forming units of the MSRA (per mL). The ASAP Solution(R) was
able to kill 91.6% of the deadly bacteria in just 10 minutes, 98.8% in 30
minutes and 99.5% in an hour. Said Keith Moeller, VP of American Biotech Labs,
"These results are very important because just 10 of these deadly bacteria per
milliliter in your bloodstream could kill an adult human. The ASAP Solution(R)
has been proven effective in killing hundreds of thousands of times that level
of bacteria. Another important factor is that the ASAP Solution(R) can be used
in, around, and on people where other toxic disinfectants cannot." The ASAP
Solution(R) has already been government approved as a surface disinfectant for
commercial, industrial, and residential use. Said Moeller, "We are doing some
additional testing to meet EPA guidelines and we anticipate having hospital
disinfectant approval in the next few months."
The product was also tested against Candida albicans yeast and the
Trichomonas vaginalis bacteria. Said Moeller, "Both of these organisms are
very problematic and can cause numerous difficulties including vaginal
infections, diaper rash, thrush etc. We believe that in the near future we may
be able to eliminate a great deal of suffering for women and children with our
product. In the in vitro testing we were able to get close to a 100% kill on
both organisms in just 10 minutes. We already have a patent pending on a
feminine hygiene product."
American Biotech Labs was recently chosen by the United States Senate
Committee for Homeland Defense as one of a few companies "that can and does
make important contributions to homeland security." American Biotech Labs is
officially listed in the Senate Registry as a company that can supply products
for homeland defense. The registry lists the ASAP Solution(TM) as a product
that is "proven to kill bacteria such as Staph, Tuberculosis, E-coli,
Salmonella, a number of yeasts and even the Anthrax spore." |
